Additionally, some IRGs with copy number amplification (HMGB1, IL17RA, and BAX) showed increased expression in tumor tissues, while some IRGs with copy number deletions (IL10, NT5E, and ENTPD1) showed decreased expression in tumor tissues. This evidence concerns the gene IL17RA and neoplasm.